Isofol Medical AB (publ) (STO:ISOFOL)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.8805
-0.0260 (-2.87%)
Aug 1, 2025, 5:29 PM CET
-2.87%
Market Cap247.51M
Revenue (ttm)n/a
Net Income (ttm)-48.66M
Shares Out281.11M
EPS (ttm)-0.30
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,084,081
Average Volume2,040,554
Open0.9085
Previous Close0.9065
Day's Range0.8800 - 0.9160
52-Week Range0.8425 - 4.8900
Beta1.16
RSI41.43
Earnings DateAug 26, 2025

About Isofol Medical AB

Isofol Medical AB (publ) operates as a clinical stage biotech company. The company develops arfolitixorin, which is in phase Ib/II clinical trial for the treatment of metastatic colorectal cancer. Isofol Medical AB (publ) was incorporated in 2008 and is based in Gothenburg, Sweden. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 5
Stock Exchange Nasdaq Stockholm
Ticker Symbol ISOFOL
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.